An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma

No clinically available biomarkers can predict pathological complete response (pCR) for esophageal squamous cell carcinomas (ESCCs) with neoadjuvant chemoradiotherapy (nCRT). Considering that antitumor immunity status is an important determinant for nCRT, we performed an integrative analysis of immu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Signal Transduct Target Ther
Main Authors: Zhang, Chaoqi, Zhang, Guochao, Sun, Nan, Zhang, Zhen, Xue, Liyan, Zhang, Zhihui, Yang, Haijun, Luo, Yuejun, Zheng, Xiaoli, Zhang, Yonglei, Yuan, Yufen, Lei, Ruixue, Yang, Zhaoyang, Zheng, Bo, Wang, Le, Che, Yun, Wang, Feng, Wang, Sihui, Gao, Shugeng, Xue, Qi, Zhang, Yi, He, Jie
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7471268/
https://ncbi.nlm.nih.gov/pubmed/32883946
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41392-020-00221-8
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki